Skip to content

Study on the mechanism of gait rehabilitation robot in improving walking dysfunction and promoting neuroplasticity in stroke patients

Study on the mechanism of gait rehabilitation robot in improving walking dysfunction and promoting neuroplasticity in stroke patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118919
Enrollment
Unknown
Registered
2026-02-12
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Experimental group:30 min of conventional rehabilitation therapy + 30 min of robot-assisted gait training
Control group:30 min of conventional rehabilitation therapy + 30 min of conventional gait training

Sponsors

Beijing Bo'ai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Subjects with unilateral limb paralysis caused by a first-ever clinical stroke and with a disease course of less than 6 months; 2.Subjects aged >18 years and 150 cm and =190 cm. 4.Normal gait prior to the first-ever stroke. 5.Functional Ambulation Category (FAC) score 3 minutes. 7.Able to cooperate with and complete the assessments. 8.Has provided informed consent and signed the study consent form.

Exclusion criteria

Exclusion criteria: 1.Unstable basic vital signs, unsuitable for rehabilitation training. 2.Presence of hemispatial neglect and/or pusher syndrome and/or walking apraxia. 3.Cardiac dysfunction (New York Heart Association functional class > III) and/or malignant arrhythmia. 4.Lower-limb swelling and pain caused by deep-vein thrombosis. 5.Marked limitation of lower-limb joint range of motion, defined as: - Passive hip extension 40°. 8.Presence of bone or joint tumors, deformities, or lower-limb amputation . 9.Lower-limb fracture that has not yet met the clinical criteria for union . 10.Presence of skin lesions in the areas corresponding to the device-binding straps or interfaces . 11.Severe lower-limb spasticity (Modified Ashworth Scale grade 4 in any lower-limb joint); 12.Subject is pregnant. 13.Has participated or is concurrently participating in any other clinical trial within 30 days. 14.No claustrophobia and no contraindications for MRI (e.g., cardiac pacemaker, intra-ocular metal foreign body, aneurysm clipped with silver ligature, or any implanted metal foreign body). 15.No history of substance abuse or psychiatric disorder. 16.The investigator considers the subject unsuitable for this clinical trial for any reason.

Design outcomes

Primary

MeasureTime frame
FAM;

Secondary

MeasureTime frame
10MWT;DTI-derived microstructural indices of white-matter fiber tract;6MWT;FM- LE;BBS;TIS;fMRI-fALFF;

Countries

China

Contacts

Public ContactXiaoxia Du

Beijing Bo'ai Hospital

364906784@qq.com+86 10 8756 9850

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026